Sullivan & Cromwell LLP Logo
  • Home
  • Lawyers
  • Practices
  • Insights
  • About
  • Careers
  • Alumni
  • Twitter icon
  • LinkedIn icon
  •  icon
  • Podcasts icon
© 2025 Sullivan & Cromwell LLP
    • Home
    • Lawyers
    • Practices
    • Insights
    • About
    • Careers
    • Alumni
    Home /  About /  News And Events /  Client Highlights
    Client Highlights

    S&C Advises Underwriters on New Horizon Health IPO on Hong Kong Exchange

    • Our Lawyers
    • Related Practices
    March 2, 2021

    China’s New Horizon Health Limited completed its US$263 million initial public offering and listing on the Hong Kong Stock Exchange on February 18.

    The offering consists of an international offering under Rule 144A and Regulation S and a public offering in Hong Kong. The Hong Kong public offering was oversubscribed by 4,135 times, making New Horizon Health the second most oversubscribed stock in the history of Hong Kong IPOs.

    New Horizon develops cancer screening tests and products. Its core product, ColoClear, is the first colorectal cancer screening test approved by the PRC National Medical Products Administration.

    S&C acted as Hong Kong and U.S. counsel to the joint sponsors and underwriters, including Goldman Sachs and UBS.

    The S&C team was led by Hong Kong partners Kay Ian Ng and Ching-Yang Lin and included Gwen Wong in Beijing. Jeffrey Hochberg and Saul Brander advised on U.S. tax matters.

    Read More
    Stay Updated

    Subscribe to stay current on S&C Insights.

    Our Lawyers

    Our Lawyers

    Saul Brander Headshot Photo
    Saul Brander
    New York
    +1-212-558-4000
    Email
    vCard
    Jeffrey D. Hochberg Headshot Photo
    Jeffrey D. Hochberg
    New York
    +1-212-558-3266
    Email
    vCard
    Ching-Yang Lin Headshot Photo
    Ching-Yang Lin
    Hong Kong
    +852-2826-8688
    Email
    vCard
    Kay Ian Ng Headshot Photo
    Kay Ian Ng
    Hong Kong
    +852-2826-8601
    Email
    vCard
    Gwen Wong Headshot Photo
    Gwen Wong
    Beijing
    +86-10-5923-5967
    Email
    vCard
    Read More

    Related Practices

    • Asia
    • Capital Markets
    • Healthcare & Life Sciences
    Sullivan & Cromwell LLP Logo
    • Twitter icon
    • LinkedIn icon
    • RSS Feed icon
    • Podcasts icon
    • Home
    • Contact Us
    • Information Policy Relating to Cookies
    • Privacy Policy
    • California Privacy Policy
    • Website Notice
    • Attorney Advertising Notice
    © 2025 Sullivan & Cromwell LLP